Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eisner

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Cancer Research Communications|March 16, 2023
Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal CancerJoel R Eisner, Kirk D Beebe, Gregory M Mayhew, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont StudyJoel R Eisner, Gregory M Mayhew, James M Davison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2024
Characterization of FGFR Alterations and Activation in Patients with High-Risk Non-Muscle-Invasive Bladder CancerJoel R Eisner, Florus C de Jong, Yoichiro Shibata, et al.
British Journal of Cancer|July 23, 2021
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experienceTracy L Rose, William H Weir, Gregory M Mayhew, et al.
British Journal of Cancer|March 12, 2022
Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experienceTracy L Rose, William H Weir, Gregory M Mayhew, et al.
The Journal of Clinical Investigation|May 3, 2017
Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancerJohn D Norris, Stephanie J Ellison, Jennifer G Baker, et al.
Molecular Cancer Therapeutics|August 16, 2020
Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen TherapyChristian K Werner, Uchechi J Nna, Hanshi Sun, et al.
Medrxiv : the Preprint Server for Health Sciences|April 12, 2022
Wastewater sequencing uncovers early, cryptic SARS-CoV-2 variant transmissionSmruthi Karthikeyan, Joshua I Levy, Peter De Hoff, et al.
Nature|July 7, 2022
Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmissionSmruthi Karthikeyan, Joshua I Levy, Peter De Hoff, et al.
Cell|December 15, 2023
Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemicsNathaniel L Matteson, Gabriel W Hassler, Ezra Kurzban, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Cancer Research Communications|March 16, 2023
Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal CancerJoel R Eisner, Kirk D Beebe, Gregory M Mayhew, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont StudyJoel R Eisner, Gregory M Mayhew, James M Davison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2024
Characterization of FGFR Alterations and Activation in Patients with High-Risk Non-Muscle-Invasive Bladder CancerJoel R Eisner, Florus C de Jong, Yoichiro Shibata, et al.
British Journal of Cancer|July 23, 2021
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experienceTracy L Rose, William H Weir, Gregory M Mayhew, et al.
British Journal of Cancer|March 12, 2022
Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experienceTracy L Rose, William H Weir, Gregory M Mayhew, et al.
The Journal of Clinical Investigation|May 3, 2017
Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancerJohn D Norris, Stephanie J Ellison, Jennifer G Baker, et al.
Molecular Cancer Therapeutics|August 16, 2020
Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen TherapyChristian K Werner, Uchechi J Nna, Hanshi Sun, et al.
Medrxiv : the Preprint Server for Health Sciences|April 12, 2022
Wastewater sequencing uncovers early, cryptic SARS-CoV-2 variant transmissionSmruthi Karthikeyan, Joshua I Levy, Peter De Hoff, et al.
Nature|July 7, 2022
Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmissionSmruthi Karthikeyan, Joshua I Levy, Peter De Hoff, et al.
Cell|December 15, 2023
Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemicsNathaniel L Matteson, Gabriel W Hassler, Ezra Kurzban, et al.
Pageof 7